Skip to main content

Biostage, Inc. (BSTG)

OTCMKTS: BSTG · Delayed Price · USD
3.66 -0.38 (-9.41%)
Sep 17, 2021 3:51 PM EDT - Market closed
Market Cap35.46M
Revenue (ttm)n/a
Net Income (ttm)-2.94M
Shares Out9.69M
EPS (ttm)-0.32
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume229
Open3.63
Previous Close4.04
Day's Range3.63 - 3.66
52-Week Range1.00 - 4.49
Beta-0.25
Analystsn/a
Price Target3.00 (-18.0%)
Est. Earnings DateNov 11, 2021

About BSTG

Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is head...

IndustryBiotechnology
Founded2007
Employees6
Stock ExchangeOTCMKTS
Ticker SymbolBSTG
Full Company Profile

Financial Performance

Financial Statements

News

Biostage™ Appoints Jerry He to Board of Directors and Completes Private Placement of $2.6 Million to Continue Its Cli...

HOLLISTON, Mass., Sept. 8, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing novel organ regeneration technology based its patented Cel...

1 week ago - PRNewsWire

Biostage Reports Q2 2021 Financial Results

HOLLISTON, Mass., Aug. 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellfr...

1 month ago - PRNewsWire

Biostage Reports Q1 2021 Financial Results

HOLLISTON, Mass., May 24, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellfra...

3 months ago - PRNewsWire

Biostage Reports 2020 Financial Results and Appointment of Interim Vice President of Finance

HOLLISTON, Mass., April 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing next-generation bioengineered esophageal implants, today a...

5 months ago - PRNewsWire